Eiger BioPharmaceuticals
ID: 5291137A biopharmaceutical company developing drugs for the treatment of rare diseases
7
Funding Rounds
$74.8m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Da*** Ap***** | - | - | - |
| Am** K. Sa***** | - | - | |
| Da*** Co** | - | - | |
| Ch******* Mu**** | - | - | - |
Funding series
Funding Series Analysis
The company Eiger BioPharmaceuticals has raised a total of $7.1m in funding over 7 rounds.
Key Insights:
- Eiger BioPharmaceuticals Series A round: $7.1m
- Celladon Corp funding round, October 2011: $200k
- Celladon Corp funding round, December 2011: $500k
- Celladon Corp funding round, February 2012: $61.35m
- Celladon Corp funding round, October 2013: $2.4m
- Eiger BioPharmaceuticals, Inc. funding round, April 2016: $3m
- Celladon Corp funding round, August 2011: $250k
Industries
Eiger BioPharmaceuticals is active in the following industries: